Abstract
TLR‐inducible zinc toxicity is an antimicrobial mechanism utilized by macrophages, however knowledge of molecular mechanisms mediating this response is limited. Here, we show that E. coli exposed to zinc stress within primary human macrophages reside in membrane‐bound vesicular compartments. Since SLC30A zinc exporters can deliver zinc into the lumen of vesicles, we examined LPS‐regulated mRNA expression of Slc30a/SLC30A family members in primary mouse and human macrophages. A number of these transporters were dynamically regulated in both cell populations. In human monocyte‐derived macrophages, LPS strongly up‐regulated SLC30A1 mRNA and protein expression. In contrast, SLC30A1 was not LPS‐inducible in macrophage‐like PMA‐differentiated THP‐1 cells. We therefore ectopically expressed SLC30A1 in these cells, finding that this was sufficient to promote zinc‐containing vesicle formation. The response was similar to that observed following LPS stimulation. Ectopically expressed SLC30A1 localized to both the plasma membrane and intracellular zinc‐containing vesicles within LPS‐stimulated THP‐1 cells. Inducible overexpression of SLC30A1 in THP‐1 cells infected with the Escherichia coli K‐12 strain MG1655 augmented the zinc stress response of intracellular bacteria and promoted clearance. Furthermore, in THP‐1 cells infected with an MG1655 zinc stress reporter strain, all bacteria contained within SLC30A1‐positive compartments were subjected to zinc stress. Thus, SLC30A1 marks zinc‐containing compartments associated with TLR‐inducible zinc toxicity in human macrophages, and its ectopic over‐expression is sufficient to initiate this antimicrobial pathway in these cells. Finally, SLC30A1 silencing did not compromise E. coli clearance by primary human macrophages, suggesting that other zinc exporters may also contribute to the zinc toxicity response.
Keywords: antimicrobial, E. coli, host‐pathogen, metal ions, zinc toxicity, zinc transporters
Graphical Abstract
The zinc transporter SLC30A1 is LPS‐inducible in human macrophages and can deliver a zinc toxicity response against intracellular Escherichia coli.
Abbreviations
- BMM
bone marrow‐derived macrophages
- CLEM
correlative light‐electron microscopy
- EV
empty vector
- HMDM
human monocyte‐derived macrophages
- MCS
multiple cloning site
- p.i.
post‐infection
- qPCR
quantitative PCR
1. INTRODUCTION
macrophages and other innate immune cells utilize an array of antimicrobial mechanisms to defend against pathogenic bacteria. 1 One such strategy, nutritional immunity, refers to the competition between host cells and invading microorganisms for essential nutrients and metal ions. 2 For example, neutrophils secrete the zinc and manganese‐binding protein calprotectin to restrict availability of these critical trace elements to bacteria, thus limiting their growth and survival. 3 Several pathogens counteract these and other innate immune responses by employing sophisticated mechanisms to acquire essential metal ions. 4 For example, Salmonella uses the ZnuABC zinc uptake system for host colonization 5 and to defend against innate immune‐mediated nitrosative stress. 6
In recent years, it has become clear that specific trace elements such as zinc can also be harnessed by innate immune cells as antimicrobial agents to combat bacterial infection. 7 In Mycobacteria‐infected macrophages exposed to inflammatory cytokines, phagosomal zinc concentrations were reported to reach millimolar concentrations. 8 Mycobacterium tuberculosis upregulates heavy metal efflux P‐type ATPases in the intramacrophage environment, with an accumulation of zinc within bacteria‐containing phagosomes also being observed. 9 Consistent with this, TLR‐mediated macrophage activation triggers the mobilization of zinc into vesicular‐like structures that co‐localize with engulfed E. coli, with intracellular bacteria producing a transcriptional response consistent with zinc poisoning. 10 The zinc toxicity response is also deployed by the soil amoeba Dictyostelium discoideum, suggesting this is an ancient host defense pathway. 11 In keeping with a central role of zinc poisoning in innate immune antimicrobial responses, the bacterial pathogens Salmonella 10 and uropathogenic E. coli 12 are able to both resist and evade this response. Mechanisms by which mobilized zinc exerts antimicrobial effects within innate immune cells are unknown. However, studies on bacteria alone have implicated induced copper deficiency, 13 manganese deficiency resulting in increased sensitivity to oxidative stress, 14 , 15 the replacement of other cations in essential enzymes, 7 and disruption of iron‐sulfur (4Fe‐S) biogenesis with consequential arrest of key metabolic pathways 16 , 17 as factors that contribute to the antimicrobial effect of zinc. Interestingly, zinc can synergize with reactive oxygen species to limit E. coli growth. 12 Thus, zinc toxicity could also act in a combinatorial fashion with other innate immune antimicrobial pathways.
Despite existing knowledge of innate immune‐mediated zinc toxicity, we still have a very limited understanding of the molecular processes underpinning this response. Mammalian zinc homeostasis is tightly regulated by 2 families of transporters, the ZIP/SLC39A family that delivers zinc to the cytoplasm and the ZnT/SLC30A family that moves zinc from the cytoplasm to the extracellular space or to the lumen of organelles. 18 SLC39A zinc importers likely contribute to the uptake and thus availability of intracellular zinc for the zinc toxicity pathway. However, macrophage‐expressed SLC39A transporters have mainly been studied in the context of regulation of inflammatory responses. For example, SLC39A8 is up‐regulated in human monocytes and macrophages in response to either TNF or LPS, 19 with this being important for control of inflammatory cytokine production. 20 SLC39A8 functions as a negative regulator of NF‐κB, as zinc can directly bind and inhibit IκB kinase. 19 Some studies have also investigated the roles of SLC30A zinc exporters in innate immune functional responses. LPS up‐regulates expression of Slc30a1, Slc30a4, and Slc30a6 in murine dendritic cells, with regulated zinc trafficking linked to antigen presentation. 21 GM‐CSF increased mRNA levels of Slc30a4 and Slc30a7 in murine peritoneal macrophages, with the subsequent sequestration of zinc in the Golgi apparatus being associated with impaired survival of the intracellular fungal pathogen Histoplasma capsulatum. 22 In contrast, while IL‐4 stimulation of bone marrow murine macrophages similarly induced Slc30a4 expression, this induction promotes a SLC30A4‐dependent increase in intracellular zinc that favors survival of H. capsulatum, 23 suggesting complex roles for individual zinc transporters in host defense. In this study, we focused on the SLC30A zinc exporter family and demonstrate that SLC30A1 is sufficient to deliver a zinc toxicity response against intramacrophage bacteria.
2. MATERIALS AND METHODS
Extended methods describing bacterial strains, correlative light‐electron microscopy (CLEM), infection assays, lentiviral construct generation, immunoblotting, flow cytometry, quantitative real time PCR (qPCR), and selective gene silencing can be found in the Supplementary material.
2.1. Ethics statement
All work involving primary human cells was approved by The University of Queensland Medical Research Ethics Committee (Certificate number 2013001519). Work involving mice was approved by the University of Queensland Animal Ethics Committee (Approval number IMB/123/18).
2.2. Mammalian cell culture
To generate human monocyte‐derived macrophages (HMDM), CD14+ monocytes were isolated from human buffy coats (Australian Red Cross Blood Service) and cultured for 7 days with 150 ng/ml recombinant human CSF‐1 (University of Queensland Protein Expression Facility), as previously described. 12 To generate mouse bone marrow‐derived macrophages (BMM), bone marrow cells from the femurs and tibias of C57BL/6 mice were cultured for 7 days as previously described. 12 Human monocytic THP‐1 cells were obtained from the American Tissue Culture Collection. Non‐adherent THP‐1 cells were differentiated into macrophages in presence of 30 ng/ml PMA (Sigma‐Aldrich) for 48 h.
2.3. Inducible gene expression in THP‐1 cells
The lentiviral system utilizing pF_TRE3G_PGK_puro (hereafter pLenti_EV: kindly provided by James Murphy, Walter and Elizabeth Hall Institute of Medical Research) for doxycycline‐inducible gene expression has previously been described. 24 , 25 Details on specific lentiviral expression constructs can be found in the Supplementary material and Supplementary Table 1. pLenti_MCS (Empty Vector) or pLenti_SLC30A1_V5 was introduction into THP‐1 cells by lentiviral transduction, as previously described. 25 , 26 Briefly, Lipofectamine 2000 (Invitrogen) in OptiMEM was combined with pCMV‐dR8.2 dvpr and pCMV_VSV‐G (Addgene), along with the appropriate DNA transfer plasmid (pLenti_EV or pLenti_SLC30A1_V5). Viral particles were harvested at 24 and 48 h post‐transfection and applied to non‐differentiated THP‐1 cells via a 2 h, 1000 × g spinfection at 35°C. Cells were subsequently maintained in 1 μg/ml puromycin (Sigma‐Aldrich). Inducible overexpression of SLC30A1 was confirmed through treatment with 100 ng/ml doxycycline (Sigma‐Aldrich) for 24 h, with subsequent experiments proceeding as described.
2.4. Confocal microscopy
Immunofluoresence imaging of fixed cells was performed using a Zeiss Axiovert 200 Upright Microscope Stand with LSM 710 Meta Confocal Scanner. Cells grown on coverslips were washed twice with PBS and then fixed in 4% PFA for 10 min. Nuclear DNA was stained with 1 μg/ml DAPI (Life Technologies). Intracellular zinc was detected by incubating fixed cells with 5 μM FluoZin‐3 AM (Life Technologies), as previously described. 10 Lentivirally transduced THP‐1 cells were washed with PBS, permeabilized, and blocked with 0.1% BSA, before being incubated with anti‐V5 and anti‐mouse Alexa‐647 Abs in 0.1% BSA, respectively (see Supplementary Table 2 for concentrations). DAPI, GFP, mCherry, and Alexa‐647 were excited with laser emission of 405, 488, 561, and 647 nm, respectively. Blinded, unbiased quantification was performed through examination of images (minimum 65 cells per experiment) via Image J, with cells scored for the presence/absence of zinc puncta or the presence and number of fluorescent bacteria.
2.5. Statistical analyses
Individual experiments were typically performed in experimental duplicate or triplicate, with mean values taken from each experiment for combining data from at least 3 experiments for statistical analyses. Prism 5 and/or 7 software was used to perform the specific statistical tests that are indicated in the individual figure legends.
3. RESULTS AND DISCUSSION
3.1. Zinc‐stressed E. coli reside within membrane‐bound compartments in human macrophages
E. coli zntA encodes a zinc efflux system that confers zinc resistance, as originally demonstrated through transposon mutagenesis, targeted gene deletion and gene complementation studies. 27 , 28 We previously showed that the E. coli K‐12 strain MG1655 is exposed to zinc stress during macrophage infection, as evidenced by intramacrophage expression of zinc‐inducible zntA and reduced intramacrophage survival of a zntA mutant strain. 10 , 12 To track this antimicrobial response, we also developed a zinc stress reporter strain (MG1655 pGcCzntAp), which constitutively expresses GFP and inducibly expresses mCherry when bacteria are subjected to zinc stress. 12 To further investigate this phenomenon, we utilized CLEM to visualize MG1655 pGcCzntAp within HMDM (Fig. 1). Live imaging of this zinc stress reporter strain confirmed the deployment of zinc toxicity against MG1655 pGcCzntAp at 8 h post‐infection (p.i.) (Fig. 1A). Re‐imaging the same cells via serial section transmission electron microscopy enabled visualization of intracellular E. coli, as well as their correlation with initial confocal images. This analysis revealed that both non‐zinc‐stressed (GFP+ve/mCherry−ve) and zinc‐stressed (GFP+ve/mCherry+ve) MG1655 pGcCzntAp reside within membrane‐bound compartments (Fig. 1B). Thus, there is likely to be a role for a member (or members) of the zinc exporter family of transporters in the delivery of antimicrobial zinc from the cytoplasm to these vesicular compartments. Furthermore, by comparison to mCherry−ve MG1655 (Fig. 1B, top inset), mCherry+ve bacteria (Fig. 1B, bottom inset) exhibited a distorted morphology, perhaps reflecting stress and/or membrane perturbation.
3.2. Zinc transporter SLC30A1 is constitutively expressed and further upregulated by LPS in human macrophages
To gain mechanistic insights into the delivery of antimicrobial zinc, we next profiled the LPS‐regulated expression of the family of Slc30a/SLC30A zinc transporters in murine BMM (Fig. 2A) and HMDM (Fig. 2B). LPS significantly up‐regulated Slc30a4 and Slc30a7 mRNA levels in BMM, with a trend for increased Slc30a5 and Slc30a9 expression also observed (Fig. 2A). Slc30a2, Slc30a3, Slc30a8, and Slc30a10 were all expressed at very low levels in these cells, but LPS treatment also caused a consistent, though non‐significant, elevation in their mRNA expression (data relative to unstimulated control, Supplementary Fig. S1A). In HMDM, LPS significantly increased the expression of SLC30A1 and SLC30A7, with SLC30A5 mRNA levels being transiently down‐regulated at 8 h post‐stimulation (Fig. 2B). Although absolute mRNA levels were very low, there was also a trend for increased expression of SLC30A10, the most closely related SLC30A family member to SLC30A1 29 (data relative to unstimulated control, Supplementary Fig. S1B). Given that many Slc30a transporters were LPS‐inducible at the mRNA level in BMM (Fig. 2A; Supplementary Fig. S1A), while the regulated expression of SLC30A family members was more restricted in HMDM, we subsequently focused on human macrophages. In HMDM, SLC30A1 was particularly highly expressed and LPS‐inducible at both the mRNA (Fig. 2B) and protein level (Fig. 2C). LPS‐inducible SLC30A1 was detected as ∼75 and ∼150 kDa in size in HMDM, as confirmed by gene silencing in these cells (Fig. 2D). This raises the possibility that SLC30A1 in macrophages may exist as a tightly bound multimeric complex and/or glycosylated dimer in addition to a glycosylated monomer. 30 Similar observations were previously made for the LPS‐inducible expression of the zinc importer SLC39A8 in human macrophages. 19 We note that the 75 kDa monomer was the most abundantly expressed form of SLC30A1 in HMDM (Fig. 2C, high exposure blot). Interestingly, monomeric SLC30A1 consistently ran at a slightly higher molecular weight in LPS‐treated versus control HMDM, suggestive of an LPS‐inducible post‐translational modification. A previous study demonstrated that SLC30A1 mRNA levels were increased in human macrophages following Mycobacterium tuberculosis infection. 9 Thus, it is likely that multiple microbial stimuli up‐regulate the expression of this zinc transporter.
3.3. Ectopic expression of SLC30A1 in THP‐1 cells drives zinc‐containing vesicle formation
In contrast to observations in HMDM, LPS did not up‐regulate SLC30A1 mRNA expression in PMA‐differentiated macrophage‐like THP‐1 cells (Supplementary Fig. S2A), despite these cells being LPS‐responsive as assessed by TNF expression (Supplementary Fig. S2B). Thus, we used a doxycycline‐inducible system to ectopically express SLC30A1 in these cells for investigation of its contributions to the macrophage zinc toxicity response. Doxycycline induced SLC30A1 mRNA expression in THP‐1 cells transduced with a lentiviral construct for SLC30A1, but not empty vector (EV), as expected (Supplementary Fig. S2C). Doxycycline‐inducible epitope‐tagged (V5) SLC30A1 expression in these cells was confirmed by both immunoblotting (Fig. 3A) and flow cytometry (Fig. 3B). In these cells, overexpressed SLC30A1_V5 was detectable at ∼75 kDa (Fig. 3A). However, a weakly expressed higher order complex (∼150 kDa, high exposure blot) was again detected, similar to our observation in HMDM (Fig. 2C).
We next examined the localization of SLC30A1 in macrophages, particularly in relation to LPS‐inducible zinc‐containing vesicles. SLC30A1 has been reported to localize exclusively to the plasma membrane of baby hamster kidney cells, 31 , 32 rat astroglial cells, 33 and rat cortical neurons. 34 In the absence of ectopic SLC30A1 expression, LPS induced the formation of zinc vesicles in PMA‐differentiated THP‐1 cells, as detected by FluoZin‐3 staining (Fig. 3C). Notably, the staining pattern of these LPS‐inducible zinc vesicles was not as pronounced as we have previously observed in HMDM, 10 , 12 being much more sparse and heterogeneous on a population and individual cell level. Upon induction of V5‐tagged SLC30A1 in THP‐1 cells, we observed that SLC30A1 localized to both the plasma membrane and intracellular vesicular structures (Fig. 3D). Interestingly, treatment with doxycycline to induce SLC30A1 expression increased the percentage of FluoZin‐3‐positive THP‐1 cells, with the effect being similar to that observed with LPS stimulation (Fig. 3E). Importantly, doxycycline alone did not have this effect in pLenti_EV‐transduced control cells (Fig. 3F). This suggests that the overexpression of SLC30A1 alone is sufficient to mobilize zinc in THP‐1 cells in a similar fashion to the response triggered by LPS. This hypothesis is further supported by the observation that FluoZin‐3‐stained zinc was often detected within SLC30A1_V5‐positive vesicles (Fig. 3D). We note, however, that this co‐localization was not uniform within a population of macrophages, likely because of the dynamic nature of zinc mobilization.
Although SLC30A1 can prevent cellular zinc toxicity via plasma membrane efflux, 30 , 31 examination across a broader range of cell types also supports a contribution to intracellular zinc redistribution. In a human keratinocyte cell line, SLC30A1 localized to the endoplasmic reticulum, nuclear membrane, and Golgi, and was found to regulate the intracellular distribution of zinc, but not the overall cellular concentration. 35 SLC30A1 was also reported to be expressed at both the plasma membrane and in intracellular compartments in rat mammary glands at different stages of lactation, as well as in mouse mammary epithelial cells. 36 Indeed, a recent study examining the regulation and modification of SLC30A1 in human pancreatic cancer cells in response to zinc fluctuations concluded that the molecular mechanisms underlying control of zinc homeostasis by SLC30A1 are more complex than previously thought. 30 Thus, the localization and functions of SLC30A1 appear to be highly dependent on both cell type and the specific cellular signals received.
3.4. SLC30A1 subjects engulfed E. coli to a zinc stress antimicrobial response in PMA‐differentiated THP‐1 cells
We next investigated whether the induction of SLC30A1 increased zntA mRNA expression within macrophages. In pLenti_SLC30A1_V5‐transduced THP‐1 cells, doxycycline treatment prior to infection with MG1655 caused an ∼2‐fold increase in zntA mRNA at 8 h p.i., with this effect not observed in pLenti_EV‐transduced control cells (Fig. 4A). This is consistent with SLC30A delivering a zinc stress response to intracellular E. coli in macrophages. We then assessed if SLC30A1 overexpression affects the intracellular survival of MG1655 within THP‐1 cells. By comparison to wild‐type MG1655, intracellular loads of the zinc‐sensitive MG1655ΔzntA mutant that is deficient in the ZntA zinc efflux system 10 , 12 were reduced in EV THP‐1 cells in the presence or absence of doxycycline at 24 h p.i. (Fig. 4B; Supplementary Table 3). This confirms that zinc export contributes to the survival of MG1655 in THP‐1 cells, as was previously observed in E. coli‐infected HMDM, where zntA was both deleted and complemented. 9 We note, however, that the effect of zntA deletion on survival within THP‐1 cells was less pronounced than previously observed for primary human macrophages. 12 Interestingly, doxycycline‐mediated induction of SLC30A1 expression reduced the intracellular bacterial loads of wild‐type MG1655 to levels similar to those observed with the zntA mutant strain. This suggests that the overexpression of SLC30A1 may overcome the resistance of wild‐type MG1655 to the macrophage zinc toxicity response. This effect was not due to a reduction in the initial uptake, as there was no difference in intracellular bacterial loads for either wild‐type MG1655 or MG1655ΔzntA from either pLenti_EV‐ or pLenti_SLC30A1‐transduced cells at 2 h p.i. (Supplementary Fig. S2D).
We next utilized the MG1655 zinc stress reporter strain 12 (Fig. 1), in conjunction with our inducible THP‐1 cell system, to further investigate the capacity of SLC30A1 to elicit an antimicrobial response. As expected, we noted heterogeneity in SLC30A1_V5 expression across the population of pLenti_SLC30A1‐transduced THP‐1 cells after treatment with doxycycline. We took advantage of this heterogeneity, quantifying numbers of MG1655 bacteria within SLC30A1‐positive (V5+ve) versus SLC30A1‐negative (V5−ve) cells within the same population of THP‐1 cells after doxycycline‐mediated induction of SLC30A1_V5 expression. This revealed that there was no difference in intracellular bacterial loads between V5+ve and V5−ve cells at 4 h p.i (Fig. 4C). At this time point, SLC30A1_V5 localized either predominantly at the plasma membrane or at both the plasma membrane and on intracellular vesicular structures (Fig. 4D) of MG1655‐infected THP‐1 cells. MG1655 found within these SLC30A1_V5‐marked structures were consistently zinc‐stressed (mCherry+ve) (Fig. 4D). By 8 h p.i., significantly reduced bacterial loads were observed in V5+ve cells as compared to V5−ve cells (Fig. 4E). At this time point, SLC30A1_V5 predominantly localized to the plasma membrane of cells that did not contain bacteria, with the majority of MG1655 within V5−ve THP‐1 cells found to be only weakly mCherry+ve (Fig. 4F). These data represent the first localization studies of SLC30A1 within macrophages, and, combined with the heightened zinc stress gene signature (Fig. 4A) and enhanced clearance (Fig. 4B, E) of MG1655 in SLC30A1_V5‐expressing THP‐1 cells, strongly support a role for SLC30A1 in the delivery of zinc toward engulfed E. coli to initiate a late‐stage zinc toxicity antimicrobial response.
3.5. SLC30A1 is not essential for bacterial killing in primary human macrophages
Somewhat surprisingly, silencing of SLC30A1 in HMDM (Fig. 5A, see also Fig. 1D) did not have any impact on the clearance of either wild‐type MG1655 or MG1655ΔzntA (Fig. 5B and C; Supplementary Table 4). Furthermore, reduced survival of the MG1655ΔzntA compared to wild‐type MG1655 at 24 h was still apparent (Fig. 5C), suggesting that the zinc toxicity response was effectively engaged in SLC30A1‐silenced HMDM. The lack of effect of SLC30A1 silencing on bacterial clearance could reflect the complexities of the zinc toxicity pathway (see Section 3.6 below) or be a consequence of the transfection protocol affecting SLC30A1 function in HMDM. It seems more likely, however, that it reflects redundancy in the functions of mammalian zinc exporters in delivering the zinc toxicity response in human macrophages. We note that many SLC30A family members are expressed and regulated in HMDM (Fig. 2B; Supplementary Fig. S1B). Furthermore, LPS still induced zinc‐containing vesicles in PMA‐differentiated THP‐1 cells (Fig. 3C, E, and F), despite the fact that this stimulus did not increase SLC30A1 mRNA in this cell line (Supplementary Fig. S2A). Interestingly, biomolecular fluorescence complementation 37 in MCF‐7 breast cancer cells reported the homodimerization of SLC30A1, SLC30A2, SLC30A3, SLC30A4, and SLC30A7. 38 As a homodimer, SLC30A1 localized to the plasma membrane, 38 however subsequent studies revealed that SLC30A1 also heterodimerized with SLC30A2 and SLC30A4, and that this altered its sub‐cellular localization. 39 Thus, SLC30A1 may also function in conjunction with other zinc transporters to achieve vesicular delivery of zinc to engulfed bacteria.
3.6. Additional factors that may contribute to innate immune‐mediated zinc toxicity
The role of zinc within macrophage antimicrobial responses is likely complex and multi‐layered, extending beyond direct metal ion poisoning. For example, we previously found that reactive oxygen species increased the sensitivity of a uropathogenic E. coli zntA mutant to zinc. 12 This suggests that the zinc toxicity response may cooperate with other innate immune antimicrobial pathways, such as the phagocyte oxidase system. Another innate immune antimicrobial pathway that could intersect with zinc toxicity is TLR‐inducible production of nitric oxide (NO), which is generated by inducible nitric oxide synthase. 1 In Salmonella, NO triggers the mobilization of zinc from a range of zinc metalloproteins, including those involved in sensing nitrosative stress, 40 DNA binding, 41 protein synthesis and cell metabolism. 42 Consequently, effective zinc efflux is required to maintain homeostasis and permit survival of Salmonella under conditions of nitrosative stress. 42 Thus, delivery of zinc to intramacrophage bacteria via the actions of SLC30A1 and/or other transport mechanisms may enhance the antimicrobial effects of NO. We note, however, that our studies were performed in primary human macrophages that generate substantially less NO than primary mouse macrophages upon activation, because of regulatory differences between the human NOS2 and mouse Nos2 genes. 43 Nonetheless, interplay between innate immune zinc delivery systems and NO may be important during NOS2‐independent nitrosative stress responses in human cells and/or the Nos2‐mediated antimicrobial response in mice.
In summary, the LPS‐inducible zinc exporter SLC30A1 permits mobilization of zinc toward intracellular E. coli and the generation of a zinc‐mediated antimicrobial response in macrophages. On the basis of studies on the E. coli homologue, YiiP, it is likely that SLC30A1 requires a proton gradient to deliver zinc in a pH‐driven, sodium‐independent, and calcium‐sensitive manner (1:1, Zn2+/H+). 44 In the context of macrophage infection, acidification of the phagolysosome by vacuolar ATPases 45 might be predicted to subsequently permit SLC30A1‐mediated delivery of zinc into phagolysosomal compartments from the cytoplasm. This could provide a means of temporal diversification of macrophage antimicrobial responses. At this stage, our understanding of the processes regulating the formation and/or stability of the zinc‐containing compartment remain quite rudimentary, but further characterisation of the SLC30A1+ve zinc‐containing compartment should generate new insights into these processes. In the longer term, our findings may lead to new avenues for manipulating SLC30A1 expression or function to enhance innate immune‐mediated zinc poisoning as an anti‐infective strategy.
AUTHORSHIP
C.J.S., J.v.P., J.B.C., and J.R. performed experiments, with assistance from R.K. and M.D.P.; D.F. and N.J.B. performed key initial studies and contributed to project design; K.M.P. and T.K. provided essential reagents (bacterial strains and anti‐SLC30A1 Ab, respectively); M.J.S., R.K., M.A.S., and R.G.P. designed and supervised the project; and C.J.S., J.v.P., R.K., and M.J.S. wrote the manuscript. All authors read and approved the final manuscript.
DISCLOSURE
The authors declare no conflict of interest.
Supporting information
ACKNOWLEDGMENTS
Confocal microscopy was performed at the Institute for Molecular Bioscience Dynamic Imaging Facility for Cancer Biology at The University of Queensland, which was established with the support of the Australian Cancer Research Foundation. The authors acknowledge the use of the Protein Expression Facility, as well as the Microscopy Australia Research Facility at the Centre for Microscopy and Microanalysis at The University of Queensland. We thank the Australian Red Cross Blood Service for providing buffy coats for the isolation of human monocytes, James Murphy (Walter and Elizabeth Hall Institute of Medical Research, Melbourne, Australia) for providing the pF_TRE3G_PGK_puro construct, and Nicholas Condon (Institute for Molecular Bioscience, The University of Queensland) for assistance with live cell imaging in the CLEM experiments. This work was supported by National Health and Medical Research Council of Australia (NHMRC) project grants (APP1065391 and APP1144967). M.J.S. and M.A.S. are supported by NHMRC Senior Research Fellowships (APP1107914 and APP1106930, respectively), and R.K. was supported by an Australian Research Council Discovery Early Career Researcher Award Fellowship (DE1310470). R.G.P. was supported by grants and a fellowship from the NHMRC (grants APP1140064 and APP1150083 and fellowship APP1156489), and the Australian Research Council (Centre of Excellence in Convergent Bio‐Nano Science and Technology CE140100036). The funders had no role in study design, data collection and interpretation, or the decision to submit this work for publication.
Stocks CJ, von Pein J, Curson JEB, et al. LPS‐inducible SLC30A1 drives human Mϕ‐mediated zinc toxicity against intracellular Escherichia coli . J Leukoc Biol. 2021;109:287–297. 10.1002/JLB.2HI0420-160R
Contributor Information
Ronan Kapetanovic, Email: r.kapetanovic@imb.uq.edu.au.
Matthew J. Sweet, Email: m.sweet@imb.uq.edu.au.
REFERENCES
- 1. Stocks CJ, Schembri MA, Sweet MJ, Kapetanovic R. For when bacterial infections persist: Toll‐like receptor‐inducible direct antimicrobial pathways in macrophages. J Leukoc Biol. 2018;103:35‐51. [DOI] [PubMed] [Google Scholar]
- 2. Hood MI, Skaar EP. Nutritional immunity: transition metals at the pathogen‐host interface. Nat Rev Microbiol. 2012;10:525‐537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Kehl‐Fie TE, Chitayat S, Hood MI, et al. Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus . Cell Host Microbe. 2011;10:158‐164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Diaz‐Ochoa VE, Jellbauer S, Klaus S, Raffatellu M. Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front Cell Infect Microbiol. 2014;4:2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Ammendola S, Pasquali P, Pistoia C, et al. High‐affinity Zn(2+) uptake system ZnuABC is required for bacterial zinc homeostasis in intracellular environments and contributes to the virulence of salmonella enterica. Infect Immun. 2007;75:5867‐5876. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Fitzsimmons L, Liu L, Porwollik S, et al. Zinc‐dependent substrate‐level phosphorylation powers Salmonella growth under nitrosative stress of the innate host response. PLoS Pathog. 2018;14:e1007388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Stafford SL, Bokil NJ, Achard ME, et al. Metal ions in macrophage antimicrobial pathways: emerging roles for zinc and copper. Biosci Rep. 2013;33:e00049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Wagner D, Maser J, Lai B, et al. Elemental analysis of Mycobacterium avium‐, Mycobacterium tuberculosis‐, and Mycobacterium smegmatis‐containing phagosomes indicates pathogen‐induced microenvironments within the host cell's endosomal system. J Immunol. 2005;174:1491‐1500. [DOI] [PubMed] [Google Scholar]
- 9. Botella H, Peyron P, Levillain F, et al. Mycobacterial p(1)‐type ATPases mediate resistance to zinc poisoning in human macrophages. Cell Host Microbe. 2011;10:248‐259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Kapetanovic R, Bokil NJ, Achard ME, et al. Salmonella employs multiple mechanisms to subvert the TLR‐inducible zinc‐mediated antimicrobial response of human macrophages. FASEB J. 2016;30:1901‐1912. [DOI] [PubMed] [Google Scholar]
- 11. Barisch C, Kalinina V, Lefrancois LH, Appiah J, Lopez‐Jimenez AT, Soldati T. Localization of all four ZnT zinc transporters in Dictyostelium and impact of ZntA and B knockout on bacteria killing. J Cell Sci. 2018;131:jcs222000. [DOI] [PubMed] [Google Scholar]
- 12. Stocks CJ, Phan MD, Achard MES, et al. Uropathogenic Escherichia coli employs both evasion and resistance to subvert innate immune‐mediated zinc toxicity for dissemination. Proc Natl Acad Sci USA. 2019:e201820870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Hassan KA, Pederick VG, Elbourne LDH, et al. Zinc stress induces copper depletion in Acinetobacter baumannii . BMC Microbiology. 2017;17:59. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Eijkelkamp BA, Morey JR, Ween MP, et al. Extracellular zinc competitively inhibits manganese uptake and compromises oxidative stress management in Streptococcus pneumoniae . PLoS One. 2014;9:e89427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. McDevitt CA, Ogunniyi AD, Valkov E, et al. A molecular mechanism for bacterial susceptibility to zinc. PLoS Pathog. 2011;7:e1002357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Xu FF, Imlay JA. Silver(I), mercury(II), cadmium(II), and zinc(II) target exposed enzymic iron‐sulfur clusters when they toxify Escherichia coli. Appl Environ Microbiol. 2012;78:3614‐3621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Li J, Ren X, Fan B, et al. Zinc toxicity and iron‐sulfur cluster biogenesis in Escherichia coli . Appl Environ Microbiol. 2019;85:e01967‐01918. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Kambe T, Suzuki E, Komori T. Zinc transporter proteins: a review and a new view from biochemistry In: Fukada, T, Kambe T, eds. Zinc Signaling. Singapore: Springer Singapore; 2019:23‐56. [Google Scholar]
- 19. Liu M‐J, Bao S, Gálvez‐Peralta M, et al. The zinc transporter SLC39A8 is a negative feedback regulator of NF‐κB through zinc‐mediated inhibition of IKK. Cell Rep. 2013;3:386‐400. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Pyle CJ, Akhter S, Bao S, Dodd CE, Schlesinger LS, Knoell DL. Zinc modulates endotoxin‐induced human macrophage inflammation through ZIP8 induction and C/EBPβ inhibition. PLoS ONE. 2017;12:e0169531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Kitamura H, Morikawa H, Kamon H, et al. Toll‐like receptor‐mediated regulation of zinc homeostasis influences dendritic cell function. Nat Immunol. 2006;7:971‐977. [DOI] [PubMed] [Google Scholar]
- 22. Subramanian Vignesh K, Landero Figueroa JA, Porollo A, Caruso JA. Granulocyte macrophage‐colony stimulating factor induced Zn sequestration enhances macrophage superoxide and limits intracellular pathogen survival. Immunity. 2013;39:697‐710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Subramanian Vignesh K, Landero Figueroa JA, Porollo A, Divanovic S, Caruso JA. IL‐4 induces metallothionein 3‐ and SLC30A4‐dependent increase in intracellular Zn(2+) that promotes pathogen persistence in macrophages. Cell Rep. 2016;16:3232‐3246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Moujalled DM, Cook WD, Okamoto T, et al. TNF can activate RIPK3 and cause programmed necrosis in the absence of RIPK1. Cell Death Dis. 2013;4:e465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Murphy JM, Czabotar PE, Hildebrand JM, et al. The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism. Immunity. 2013;39:443‐453. [DOI] [PubMed] [Google Scholar]
- 26. Vince JE, Wong WW‐L, Khan N, et al. IAP antagonists target cIAP1 to induce TNFα‐dependent apoptosis. Cell. 2007;131:682‐693. [DOI] [PubMed] [Google Scholar]
- 27. Beard SJ, Hashim R, Membrillo‐Hernandez J, Hughes MN, Poole RK. Zinc(II) tolerance in Escherichia coli K‐12: evidence that the zntA gene (o732) encodes a cation transport ATPase. Mol Microbiol. 1997;25:883‐891. [DOI] [PubMed] [Google Scholar]
- 28. Rensing C, Mitra B, Rosen BP. The zntA gene of Escherichia coli encodes a Zn(II)‐translocating P‐type ATPase. Proc Natl Acad Sci USA. 1997;94:14326‐14331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Huang L, Tepaamorndech S. The SLC30 family of zinc transporters ‐ a review of current understanding of their biological and pathophysiological roles. Mol Aspects Med. 2013;34:548‐560. [DOI] [PubMed] [Google Scholar]
- 30. Nishito Y, Kambe T. Zinc transporter 1 (ZNT1) expression on the cell surface is elaborately controlled by cellular zinc levels. J Biol Chem. 2019;294:15686‐15697. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Palmiter RD. Protection against zinc toxicity by metallothionein and zinc transporter 1. Proc Natl Acad Sci USA. 2004;101:4918‐4923. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Palmiter RD, Findley SD. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. EMBO J. 1995;14:639‐649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Nolte C, Gore A, Sekler I, et al. ZnT‐1 expression in astroglial cells protects against zinc toxicity and slows the accumulation of intracellular zinc. Glia. 2004;48:145‐155. [DOI] [PubMed] [Google Scholar]
- 34. Qin Y, Thomas D, Fontaine CP, Colvin RA. Silencing of ZnT1 reduces Zn2+ efflux in cultured cortical neurons. Neurosci Lett. 2009;450:206‐210. [DOI] [PubMed] [Google Scholar]
- 35. Lazarczyk M, Pons C, Mendoza JA, Cassonnet P, Jacob Y, Favre M. Regulation of cellular zinc balance as a potential mechanism of EVER‐mediated protection against pathogenesis by cutaneous oncogenic human papillomaviruses. J Exp Med. 2008;205:35‐42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Kelleher SL, Lonnerdal B. Zn transporter levels and localization change throughout lactation in rat mammary gland and are regulated by Zn in mammary cells. J Nutr. 2003;133:3378‐3385. [DOI] [PubMed] [Google Scholar]
- 37. Hu CD, Chinenov Y, Kerppola TK. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol Cell. 2002;9:789‐798. [DOI] [PubMed] [Google Scholar]
- 38. Lasry I, Golan Y, Berman B, Amram N, Glaser F, Assaraf YG. In situ dimerization of multiple wild type and mutant zinc transporters in live cells using bimolecular fluorescence complementation. J Biol Chem. 2014;289:7275‐7292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Golan Y, Berman B, Assaraf YG. Heterodimerization, altered subcellular localization, and function of multiple zinc transporters in viable cells using bimolecular fluorescence complementation. J Biol Chem. 2015;290:9050‐9063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Henard CA, Tapscott T, Crawford MA, et al. The 4‐cysteine zinc‐finger motif of the RNA polymerase regulator DksA serves as a thiol switch for sensing oxidative and nitrosative stress. Mol Microbiol. 2014;91:790‐804. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Schapiro JM, Libby SJ, Fang FC. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc Natl Acad Sci USA. 2003;100:8496‐8501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Frawley ER, Karlinsey JE, Singhal A, et al. Nitric oxide disrupts zinc homeostasis in salmonella enterica serovar typhimurium. MBio. 2018;9:e01040‐01018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Vitek MP, Brown C, Xu Q, Dawson H, Mitsuda N, Colton CA. Characterization of NO and cytokine production in immune‐activated microglia and peritoneal macrophages derived from a mouse model expressing the human NOS2 gene on a mouse NOS2 knockout background. Antioxid Redox Signal. 2006;8:893‐901. [DOI] [PubMed] [Google Scholar]
- 44. Shusterman E, Beharier O, Shiri L, et al. ZnT‐1 extrudes zinc from mammalian cells functioning as a Zn(2+)/H(+) exchanger. Metallomics. 2014;6:1656‐1663. [DOI] [PubMed] [Google Scholar]
- 45. Beyenbach KW, Wieczorek H. The V‐type H+ ATPase: molecular structure and function, physiological roles and regulation. J Exp Biol. 2006;209:577‐589. [DOI] [PubMed] [Google Scholar]
- 46. Takasato M, Er PX, Chiu HS, et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature. 2015;526:564‐568. [DOI] [PubMed] [Google Scholar]
- 47. Bokil NJ, Totsika M, Carey AJ, et al. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages. Immunobiology. 2011;216:1164‐1171. [DOI] [PubMed] [Google Scholar]
- 48. Luo L, Bokil NJ, Wall AA, et al. SCIMP is a transmembrane non‐TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages. Nat Commun. 2017;8:14133‐14133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Blattner FR, Plunkett G, 3rd , Bloch CA, et al. The complete genome sequence of Escherichia coli K‐12. Science. 1997;277:1453‐1462. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.